with abnormal arterial muscularisation leading to pulmonary hypertension. Because underlying molecular changes are imperfectly known and sometimes controversial, we determined key factors of angiogenesis along intrauterine development, focusing at the angiopoietin (ANG)/TIE2 system. Lung specimens from medical terminations of pregnancy (9 to 37wk) were used, including LH due to congenital diaphragmatic hernia (CDH) or other causes, and non-pulmonary disease samples used as controls. ELISA determination indicated little ANG1 change during pregnancy and no effect of LH whereas TIE2 declined similarly between 9 and 37 wk in LH and controls. By contrast, ANG2 markedly increased in LH from 24 wk whereas it remained stable in controls. Because VEGF increased also, this was interpreted as an attempt to overcome vascular underdevelopment. Hypothesizing that its inefficiency might be due to impaired downstream mechanism, eNOS was determined by semi-quantitative western blot and found to be reduced about 75 , mostly in the instance of CDH. In conclusion, angiogenesis remains defective in hypoplastic lungs despite reactive % enhancement of VEGF and ANG2 production, which could be due, at least in part, to insufficient eNOS expression. In the present study, we focused on the angiopoietin (ANG)/TIE2 system as potential candidate regulators of vascular remodeling in LH. Vasculogenesis and angiogenesis are mainly regulated by the interplay between VEGF and angiopoietins. ANG1 and 2 bind the endothelial receptor tyrosine kinase TIE-2. During normal development, ANG1 and TIE2 are required for correct organization and maturation of newly formed vessels. Mice deficient for these factors die at mid gestation and display dilated vessels, diminished branching, and reduced number of small vessels ( , ). A similar phenotype was observed in mice overexpressing the Ang2 gene, indicating that 13 42 ANG2 is able to counteract ANG1 activity ( ). A number of studies, however, suggested that ANG2 displays pro-angiogenic properties 25 at high concentration ( ) or in combination with VEGF-A ( , ), revealing the complexity of ANG2 functions. In addition to its role 26 24 48
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Given these considerations, we hypothesized that the hypoplastic lung might present unbalanced expression of angiopoietins, TIE2, and VEGF, which might in turn contribute to vascular underdevelopment and lung hypertension at birth. We determined the pulmonary content of these factors in human fetuses with LH of various causes at different developmental stages, comparatively to normal fetal lungs.
This represents the first study of this pathway in human lung in the course of gestational development.
MATERIALS AND METHODS

Human lung tissue
Post mortem lung tissue samples were obtained at autopsy after medical termination of pregnancy or neonatal death Lung tissues were immediately frozen and stored at 80 C. Terminations were performed according to the July 1994 French legislation, and the study was −°u ndertaken with the agreement of the institutional Ethical Committee. Parents were informed about the procedure and issues of post mortem study, and signed consent was obtained for all included samples. The prenatal diagnosis of CDH, lung hypoplasia, and other congenital abnormalities was made by ultrasound and was confirmed by post mortem examination. Reduced lung weight and consistent histological appearance confirmed the diagnosis of pulmonary hypoplasia (lung to body weight ratio <0.015 before 28 wk of pregnancy, and <0.012 thereafter)
. Fetuses were checked for other malformations and for the presence or absence of associated [ Table 1 ] chromosomal abnormality. In the instance of CDH, the lung ipsilateral to the hernia was used. Lungs from fetuses with nonpulmonary malformations were used as controls; they appeared to be histologically normal by post mortem examination and were not hypoplastic. No cardiovascular disease was included in the control group. Clinical data are depicted in . Previous studies using those human lung Table 2 tissue samples had shown preservation of proteins and feasibility of their analysis ( ). Preservation of RNAs was by contrast insufficient 5
and inconsistent, and therefore neither quantitative study at the pre-translational level nor in situ hybridization could be performed. Fetal age (post conceptional) is used throughout the paper.
Lung histology and vascular immunohistochemistry
Because of restrictions in human tissue sampling conditions, it was not possible to proceed to lung fixation at constant pressure, and therefore to perform morphometry. Pieces of human lung tissue were fixed in formalin 24h after death. Fixed tissues were paraffin-embedded. Five-m sections were dehydrated in xylene and graded ethanol, and then stained with orcein-picroindigo-carmine. (GE Healthcare Life Sciences, Saclay, France) before exposure to Kodak BioMax MS film. Signals were quantified by densitometry (NIH Image, Betehesda, MD).
Quantitative assays for VEGF, ANG1, aANG2, and TIE2
VEGF-A , Angiopoietin-1 and -2, and TIE2 concentrations in human fetal lung tissue were assessed with commercially sensitive 165 and specific ELISA (R&D Systems, Lille, France), following the manufacturer s instructions, and normalized to total proteins. The intra ' and inter-assay coefficients of variance were less than 5 for each essay.
%
Stastistical analysis
Relationships between ANG1, ANG2, TIE2, and VEGF-A concentrations and fetal age were analyzed using linear regression 165 models, including main effects and interaction terms to compare concentrations between groups. Sensitivity analyses were performed when outliers were present. Analyses were performed using R statistical software. For eNOS data, multiple group comparisons were made using Kruskal-Wallis test, and two-group comparisons were made using the Mann-Whitney U-test. A p-value of 0.05 was considered to be the limit of statistical significance.
Results
Comparative histology and PECAM-1 immunohistochemistry
Control lungs aged 32 33 weeks (fetal age, late saccular stage) displayed large-sized, simple airspaces, relatively wide septa, and focal 
Lung contents in ANG1, ANG2, and TIE2
The concentration of ANG1, ANG2 and TIE2 proteins was determined in lung tissue samples from 69 fetuses with or without LH ranging from 9 to 37 wk of pregnancy. As already observed for other parameters in similar samples, ( ) the values were largely dispersed 5
with some overlap between groups. This seems to be inherent of this type of approach with human samples, but did not prevent from evidencing strongly significant differences between groups. In control and LH lungs, ANG1 concentration did not change significantly Figure 5C eNOS level was markedly reduced in one fetus with CDH compared to two age-matched controls.
Discussion
Successful adaptation of the newborn to extrauterine life depends upon the ability of the pulmonary circulation to undergo rapid fall in vascular resistance within the first minutes after birth. This critical step follows a lengthy series of highly orchestrated events that characterize normal growth and maturation of the fetal pulmonary circulation. Since the ANG/Tie2 system plays a crucial role in the control of vascular development in normal angiogenesis and has been found to be disordered in pathological conditions, we speculated that abnormal balance in the ANG/Tie2 system might account for the structural vascular abnormalities seen in human fetuses with lung hypoplasia. We found that the latter is associated with elevated concentration of pulmonary ANG2 during the second half of pregnancy.
Although controversial, the implication of the ANG1-Tie2 pathway in the pathogenesis of pulmonary arterial hypertension has been the object of numerous investigations ( , , ). By contrast, the role of the ANG/Tie2 system during lung development has been only 11 12 well as in the present study, this appears to be inefficient, which suggests abnormal function of effectors. To test this hypothesis, attention was paid to eNOS that we found to be decreased in fetuses with LH, especially in the instance of the one associated with CDH. Using immunohistochemistry, a previous study had evidenced no difference in pulmonary eNOS expression between fetuses with LH and age-matched controls ( ). A possible explanation for the discrepancy between this and our investigation is the lack of sensitivity of 10 immunohistochemistry to quantitatively appreciate expression changes, whereas western blotting that we used allows semi-quantitative comparison to be performed. Our finding of reduced eNOS expression in human fetuses with LH is by contrast consistent with that from another investigation conducted on arteries of newborns with CDH complicated by persistent pulmonary hypertension in which eNOS expression level was found to be decreased ( ). Moreover, in the present study, we demonstrated that eNOS reduction occurs early in the 38 course of pathological lung development. A marked reduction in hypoplastic lungs was thus observed at the canalicular stage during which intracinar capillaries develop, and was likely to be still present at saccular and alveolar stages. Interestingly, mice devoid of eNOS exhibit major defects in lung morphogenesis with a lung phenotype that closely mimics histological features of alveolar capillary dysplasia (ACD) ( ). CDH and ACD are both characterized by decreased number of alveolar units, medial thickening of small pulmonary arteries with 16 muscularization of arterioles, and thickened interalveolar septa ( ). Newborns with PPHN secondary to CDH or ACD are often 37 refractory to inhaled NO ( ). In addition treatment of lung explants with nitro-L-arginine, a NOS inhibitor, led to a significant loss in 19 branching morphogenesis ( ) and a failure of compensatory lung growth following pneumonectomy has been demonstrated in eNOS 27 knockout mice ( ). Taken together, these data provide direct evidence that substantial alterations in NO production not only contribute to 23 dysregulation of vascular tone at birth, but also disturb the molecular and cellular mechanisms that mediate the cross talk between epithelium and mesenchyme to coordinate airway and vessel development during lung development.
The mechanism leading to eNOS decrease is not clear. Since physical forces regulate eNOS mRNA expression and play a crucial role in lung growth, prolonged mechanical restriction due to inadequate amniotic fluid production and/or lung compression by viscera could be responsible for the low levels of eNOS observed in fetuses with lung hypoplasia.
Rodent and lamb models have been developed and extensively used to explore the physiopathology of human CDH and to test the showed that VEGF mRNA as well as protein levels were significantly increased in lungs of nitrofen-treated rats, whereas two other studies ( , ) reported diminished VEGF expression in the same model. Similar discrepancies were found for eNOS ( , ). 7 8 29 30 This study however presents some limitations that must be considered. Firstly, and despite the fact that specimens were processed in the same way, histological investigations were performed on small lung tissue samples obtained at autopsy and fixed after sample removal, a procedure known to influence histological interpretation. Next, the relatively small number of fetuses examined, especially at the alveolar stage, may have contributed to reduce the power of the study. Investigation on a larger population is therefore desirable to confirm the present findings. Finally, the mechanism leading to, and the biological significance of ANG2 and VEGF upregulation in fetuses with LH are uncertain. It must be underlined that the increase of ANG2 expression during pregnancy may counteract the specific vessel-stabilizing effects of ANG1, or mediate deleterious effects, as reported in the instances of bronchopulmonary dysplasia ( ) or of 4 acute septic lung injury ( ). 32
Collectively, our results nonetheless document further the abnormal vascular development associated with LH. Enhancing pulmonary eNOS appears as a therapeutic objective in this condition. This is further supported by the finding that NO-donor promoted branching morphogenesis in control and nitrofen-exposed fetal lung explants ( , , ). 27 36 46 Ackowledgements: Immunostaining of platelet endothelial cell adhesion molecule-1 (PECAM-1). Lung sections from fetuses aged 32 33 weeks (fetal age) -without (A, control lung) or with (B, CDH, and C, urogenital defect) LH were immunostained with mouse monoclonal anti-human PECAM-1 antibody and counterstained with hematoxylin. All pictures are at same magnification. Control fetuses had extensive staining of endothelial cells within septa, whereas immunostaining appeared less intense in the hypoplastic lungs that displayed reduced complex intertwining of alveolar capillaries.
Figure 3
Scatter plots of ANG1, ANG2, and TIE2 concentrations (pg/mg protein) in human lung fetuses as a function of fetal age (wk). Individual values are shown: open, black, and grey points correspond to control fetuses, fetuses with pulmonary hypoplasia due to CDH, and fetuses with pulmonary hypoplasia due to other causes, respectively. Solid line represents the regression line of control fetuses, hatched line represents the regression line of fetuses with lung hypoplasia (either cause). Two extreme ANG1, ANG2, and TIE2 outliers were discarded for calculating scatters plots. Difference between control and LH fetuses (CDH other causes) was significant only for Ang2 that was increased in late 
